CXCL12 and metabolic dysfunction-associated steatotic liver disease: In non-alcoholic steatohepatitis (NASH) animal experiments, it has been demonstrated that CXCR4/CXCL12 facilitates CD4T cell-dependent migration to the liver, promoting the recruitment of hepatic lymphocytes and the progression of MASLD (28).